Zhang Zhen-Xin, Roman Gustavo C, Hong Zhen, Wu Cheng-Bing, Qu Qiu-Ming, Huang Jue-Bing, Zhou Bing, Geng Zhi-Ping, Wu Ji-Xing, Wen Hong-Bo, Zhao Heng, Zahner Gwendolyn E P
Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Lancet. 2005;365(9459):595-7. doi: 10.1016/S0140-6736(05)17909-4.
A cross-sectional prevalence study of Parkinson's disease in China was undertaken in 1997-98. We assessed 29?454 residents aged > or =55 years from 79 rural and 58 urban communities in Beijing, Xian, and Shanghai, who were selected through stratified, multistage, cluster sampling. With a standardised diagnostic protocol, we identified 277 people with the disease. Prevalence of Parkinson's disease for those aged > or =65 years was 1.7% (95% CI 1.5-1.9). We estimate that 1.7 million people in China have the disease (aged > or =55 years). Our findings suggest that prevalence of Parkinson's disease in China is similar to that in developed countries.
1997年至1998年,在中国开展了一项帕金森病横断面患病率研究。我们评估了来自北京、西安和上海79个农村社区和58个城市社区的29454名年龄≥55岁的居民,这些居民是通过分层、多阶段整群抽样选取的。采用标准化诊断方案,我们识别出277例帕金森病患者。65岁及以上人群中帕金森病的患病率为1.7%(95%可信区间1.5 - 1.9)。我们估计中国有170万人患有帕金森病(年龄≥55岁)。我们的研究结果表明,中国帕金森病的患病率与发达国家相似。